Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for Anthracycline-Induced Cardiotoxicity in Breast Cancer
NCT02053974Phase 4Completed
- Sponsor
- Erciyes University
- Start
- Sep 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in anthracycline-induced cardiotoxicity, sponsored by Erciyes University. Started Sep 2011; status: completed.
02
Drugs
spironolactone
03
Conditions
anthracycline-induced cardiotoxicity
Beyond the preview
Go deeper on NCT02053974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053974.